Drug Profile
Lifarizine
Alternative Names: RS 87476Latest Information Update: 25 Jan 2017
Price :
$50
*
At a glance
- Originator Roche Palo Alto LLC
- Developer Roche Palo Alto
- Class Anti-ischaemics; Imidazoles; Nootropics; Piperazines; Small molecules; Vasodilators
- Mechanism of Action Calcium channel antagonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Stroke
Most Recent Events
- 24 Jan 2017 Discontinued - Phase-II for Stroke in USA (unspecified route)
- 12 Jan 2001 Profile reviewed but no significant changes made
- 26 Feb 1997 Suspended-II for Stroke in USA (Unknown route)